drugset / Trial / NCT00692042

Study to Investigate Safety, Tolerability and Pharmacokinetics of a Single Ascending Dose of AZD1704

NCT00692042 ↗

Phase 1 Completed 80 enrolled AstraZeneca
RandomizedParallel-groupQuadruple-blind

Summary

The primary aim for this study is to investigate the safety and tolerability of the AZD1704, first time in man.

Timeline

Start
2008-03
Primary completion
2008-06
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD1704 Unknown — Oral

Indications

No indication recorded.